Another study rejected the commonly accepted upper limit for gray-zone PSA (10 ng/ml) and found similar PCa detection rates for patients with a PSA of 4-10 ng/ml and 10-20 ng/ml (20.5% vs. 21.6%; p=0.854) [9]. The gene discussed is KLK3; the disease is posterior cortical atrophy.